Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rabourn Amy Zaremba currently holds 188,671 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rabourn Amy Zaremba has been a net seller of OCUP stock. They have purchased $0 and sold $8.5K worth of shares.
Rabourn Amy Zaremba's most recent insider trade was on Apr 23, 2026, when they sold 1,641 shares at $5.20 per share.
Rabourn Amy Zaremba serves as Executive at Ocuphire Pharma, Inc. (OCUP). They have executed 7 insider transactions totaling $8.5K over their tenure at the company.
Rabourn Amy Zaremba holds the position of Executive at Ocuphire Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Rabourn Amy Zaremba has shown a selling trading pattern, with $0 in total purchases and $8.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rabourn Amy Zaremba was on Jan 10, 2024, when they sold $12.9K worth of OCUP shares. This transaction involved 3,950 shares at $3.27 per share.
Rabourn Amy Zaremba currently owns 188,671 shares of Ocuphire Pharma, Inc. (OCUP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rabourn Amy Zaremba's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rabourn Amy Zaremba has 7 Form 4 filings on record as an insider at Ocuphire Pharma, Inc..
Set alerts for Rabourn Amy Zaremba and 40,000+ other insiders.